The Netherlands Cancer Institute: Carcinoma trials

The registry lists 15 Carcinoma studies with The Netherlands Cancer Institute as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 6Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Towards Cure Via Only Ultra-short ICB in CSCCRecruitingNCT06823479Phase 2
• Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVCRecruitingNCT05905315Phase 2
• Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.RecruitingNCT04737382Not applicable
• Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)RecruitingNCT04192253Phase 2
• Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel ChemotherapyRecruitingNCT04161664Phase 2
• Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal CancerStatus unknownNCT04231175Not applicable
• ctDNA as a Biomarker for Treatment Response in HNSCCCompletedNCT03540563Not applicable
• Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapyCompletedNCT03387761Phase 1
• Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)CompletedNCT02938273Phase 1
• Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell CarcinomaTerminatedNCT02775006Phase 3
• Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary OriginStatus unknownNCT02695459Phase 2
• Olaparib and Radiotherapy in Head and Neck CancerActive, not recruitingNCT02229656Phase 1
• Olaparib and Radiotherapy in Inoperable Breast CancerCompletedNCT02227082Phase 1
• Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal MetastasesStatus unknownNCT01818713Phase 2
• Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal MetastasesCompletedNCT01713699Not applicable